Insider Transactions in Q3 2021 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,782
-47.54%
|
$13,910
$5.2 P/Share
|
|
Aug 02
2021
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
2,939
-37.62%
|
$8,817
$3.58 P/Share
|
|
Jul 02
2021
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
1,907
-37.56%
|
$7,628
$4.26 P/Share
|
|
Jul 02
2021
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,375
-37.38%
|
$17,500
$4.26 P/Share
|